CRL-40,941 (also referred to as fladrafinil or fluorafinil) is a wakefulness-promoting agent closely related to adrafinil and moda finil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil. It enhances wakefulness, attention capacity and vigilance, but its pharmacological profile is notably different from the amphetamines, methyl pheni date (rita lin) or coca ine. Crl-40,941 is less likely to cause jitteriness, anxiety, or excess locomotor activity - or lead to a hypersomnolent 'rebound effect' - than traditional stimulants. Subjectively, it feels smoother and cleaner than the amphetamines too. It may even be anxiolytic. The normal elimination half-life of CRL-40,941 in humans is between 12 - 15 hours. So it's worth fine-tuning one's dosage schedule accordingly.
Recently CRL-40,941 has been fond that it can provide better results than those achieved with current treatments based on psychostimulants, would treat symptoms resistant to current treatments with no symptom rebound effect, and would have a low poisons.
CRL-40,941 is a molecule similar to moda finil and adrafinil and has shown that it is more effective than these two molecules in their indications with fewer side effects. It is a wakefulness-promoting agent used for treatment of disorders such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Finally, it will be to positively modulate Glutamate receptors as well which is theorized to be the main mechanism of action behind the cognitive benefits of this smart drug.
CRL-40,941 can use to improve student's memory and enhance their cognitive. Compare with others nootropics it is able to possible treatment for ADHD and idiopathic hypersomnia but low toxicity though not much research would prove this claim.
• Increases coordination
• Improves mood
• Helps fight fatigue
• Prevents oxidation within the brain
• Treats alcohol related brain damage